Hullon D, Taherifard E, Al-Saraireh T
Ann Med Surg (Lond). 2024; 86(3):1575-1583.
PMID: 38463117
PMC: 10923357.
DOI: 10.1097/MS9.0000000000001773.
Ergun B, Aybal Kutlugun A, Ergun M, Akturk G, Beyan E
Turk J Med Sci. 2021; 51(6):3047-3052.
PMID: 34519192
PMC: 10734815.
DOI: 10.3906/sag-2104-138.
Ingrasciotta Y, Lacava V, Marciano I, Giorgianni F, Tripepi G, D Arrigo G
BMC Nephrol. 2019; 20(1):359.
PMID: 31521117
PMC: 6744676.
DOI: 10.1186/s12882-019-1554-0.
Guirguis K
Pharm Pract (Granada). 2019; 17(1):1406.
PMID: 31015880
PMC: 6463405.
DOI: 10.18549/PharmPract.2019.1.1406.
Louw E, Chothia M
BMC Nephrol. 2017; 18(1):336.
PMID: 29178879
PMC: 5702117.
DOI: 10.1186/s12882-017-0752-x.
Renal Transplantation - Calcutta Experience.
Varma P, Sinha T, Batura D, Malik R, Kumar R, Chopra G
Med J Armed Forces India. 2016; 58(3):196-200.
PMID: 27407381
PMC: 4925334.
DOI: 10.1016/S0377-1237(02)80128-9.
Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways.
Kato H, Ishida J, Matsusaka T, Ishimaru T, Tanimoto K, Sugiyama F
PLoS One. 2015; 10(6):e0129484.
PMID: 26107632
PMC: 4479565.
DOI: 10.1371/journal.pone.0129484.
The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.
An J, Hwang J, Lee J, Chin H, Kim S, Kim D
PLoS One. 2015; 10(6):e0128632.
PMID: 26098847
PMC: 4476682.
DOI: 10.1371/journal.pone.0128632.
Individualizing anaemia therapy.
de Francisco A
NDT Plus. 2015; 3(6):519-26.
PMID: 25949459
PMC: 4421434.
DOI: 10.1093/ndtplus/sfq164.
Encapsulation of Phaseolus lunatus Protein Hydrolysate with Angiotensin-Converting Enzyme Inhibitory Activity.
Ruiz Ruiz J, Segura Campos M, Betancur Ancona D, Chel Guerrero L
ISRN Biotechnol. 2015; 2013:341974.
PMID: 25937975
PMC: 4393043.
DOI: 10.5402/2013/341974.
Blood disorders typically associated with renal transplantation.
Yang Y, Yu B, Chen Y
Front Cell Dev Biol. 2015; 3:18.
PMID: 25853131
PMC: 4365751.
DOI: 10.3389/fcell.2015.00018.
Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis.
Morishita Y, Kusano E, Nagata D
Open Cardiovasc Med J. 2014; 8:6-11.
PMID: 24611082
PMC: 3944431.
DOI: 10.2174/1874192401408010006.
Avosentan reduces albumin excretion in diabetics with macroalbuminuria.
Wenzel R, Littke T, Kuranoff S, Jurgens C, Bruck H, Ritz E
J Am Soc Nephrol. 2009; 20(3):655-64.
PMID: 19144760
PMC: 2653691.
DOI: 10.1681/ASN.2008050482.
Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.
Silverberg D, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D
Int Urol Nephrol. 2006; 38(2):295-310.
PMID: 16868702
DOI: 10.1007/s11255-006-0064-8.
Anemia in heart failure--a concise review.
Vasu S, Kelly P, Lawson W
Clin Cardiol. 2005; 28(10):454-8.
PMID: 16274092
PMC: 6653873.
DOI: 10.1002/clc.4960281003.
Anemia and heart failure.
OMeara E, Murphy C, McMurray J
Curr Heart Fail Rep. 2005; 1(4):176-82.
PMID: 16036042
DOI: 10.1007/s11897-004-0006-7.
Treatment of anemia in the patient with heart failure.
Streeter R, Mancini D
Curr Treat Options Cardiovasc Med. 2005; 7(4):327-32.
PMID: 16004863
DOI: 10.1007/s11936-005-0043-x.
Managing chronic renal insufficiency--intertwined roles of non-nephrologist and nephrologist.
Ifudu O, Friedman E
J Natl Med Assoc. 2003; 95(1):43-54.
PMID: 12656449
PMC: 2594371.
Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice.
Cole J, Ertoy D, Lin H, Sutliff R, Ezan E, Guyene T
J Clin Invest. 2000; 106(11):1391-8.
PMID: 11104792
PMC: 381466.
DOI: 10.1172/JCI10557.
